HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chotima Böttcher Selected Research

Messenger RNA (mRNA)

1/2022SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chotima Böttcher Research Topics

Disease

3Inflammation (Inflammations)
02/2024 - 12/2019
2COVID-19
02/2024 - 01/2022
2Neoplasms (Cancer)
01/2024 - 01/2021
2Multiple Sclerosis
11/2023 - 01/2022
2Crohn Disease (Crohn's Disease)
01/2022 - 12/2019
2Infections
01/2017 - 11/2015
2Stroke (Strokes)
11/2015 - 11/2015
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2024
1Breast Neoplasms (Breast Cancer)
02/2024
1Neuromyelitis Optica (Devic's Disease)
11/2023
1Obesity
02/2023
1Autoimmune Diseases (Autoimmune Disease)
01/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1Ulcerative Colitis
01/2022
1Glioma (Gliomas)
01/2021
1Major Depressive Disorder (Major Depressive Disorders)
11/2020
1Atrophy
10/2020
1Huntington Disease (Huntington's Disease)
10/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy)
12/2019
1Multiple Trauma (Multiple Injuries)
04/2016
1Nervous System Diseases (Neurological Disorders)
01/2016
1Pneumonia (Pneumonitis)
11/2015
1Neuroinflammatory Diseases
11/2015

Drug/Important Bio-Agent (IBA)

2BibenzylsIBA
01/2024 - 01/2020
2PhenanthrenesIBA
01/2024 - 01/2020
2CytokinesIBA
11/2020 - 01/2017
1Biomarkers (Surrogate Marker)IBA
04/2024
1Carboplatin (JM8)FDA LinkGeneric
02/2024
1Etoposide (VP 16)FDA LinkGeneric
02/2024
1protocatechualdehydeIBA
02/2024
1oxoflavidinIBA
02/2024
1flavidinIBA
02/2024
1RNA (Ribonucleic Acid)IBA
02/2024
1ProteomeIBA
02/2024
1Interferon Type IIBA
02/2024
1isopanduratin AIBA
02/2023
1pinostrobinIBA
02/2023
1cardamoninIBA
02/2023
1panduratin AIBA
02/2023
1FlavonoidsIBA
02/2023
1Messenger RNA (mRNA)IBA
01/2022
1AntibodiesIBA
01/2022
1Interleukin-17 (Interleukin 17)IBA
01/2022
1Sphingosine-1-Phosphate ReceptorsIBA
01/2022
1Fingolimod Hydrochloride (FTY720)FDA Link
01/2022
1VaccinesIBA
01/2022
1mRNA VaccinesIBA
01/2022
1CalciumIBA
01/2022
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2021
1Tryptophan (L-Tryptophan)FDA Link
01/2021
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2021
1Interleukin-10 (Interleukin 10)IBA
11/2020
1Interleukin-6 (Interleukin 6)IBA
11/2020
1HLA-DR Antigens (HLA-DR)IBA
11/2020
1ChemokinesIBA
11/2020
1ErythropoietinFDA Link
10/2020
1chrysotoxineIBA
01/2020
1cypripedinIBA
01/2020
1gigantolIBA
01/2020
1dendrophenolIBA
01/2020
1metreleptinIBA
12/2019
1LeptinIBA
12/2019
1Toll-Like Receptors (Toll-Like Receptor)IBA
04/2016
1LipopolysaccharidesIBA
04/2016
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
11/2015
1Cholinergic Agents (Cholinergics)IBA
11/2015
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
11/2015
1Dopamine (Intropin)FDA LinkGeneric
11/2015

Therapy/Procedure

4Therapeutics
11/2023 - 01/2016
1Immunomodulation
01/2024
1Immunotherapy
01/2021
1Vagotomy
11/2015